Clinical Trials Sponsored by AORTICA Group

Total 7669 results

AORTICA Group

Terminated

Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.

Aortic Valve Stenosis

Spain
AORTICA Group

Completed

Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI (COMPARE)

ST Elevation Myocardial Infarction

Spain
AORTICA Group
University of Salamanca

Completed

The SALMANTICOR Study (SALMANTICOR)

Structural Heart Abnormality

Spain
AORTICA Group
Instituto de Investigación Biomédica de Salamanca

Unknown

Cardiotoxicity in the Elderly (CARTIER)

Elderly | Cardiotoxicity | Cardiac Magnetic Resonance

Spain
French Africa Pediatric Oncology Group

Recruiting

Recommendations for the Treatment of Children With Burkitt's Lymphoma (GFALMB2019)

Burkitt Lymphoma

Burkina Faso, Congo, The Democratic Republic of the, Côte D'Ivoire, Mali, Madagascar, Senegal
French Africa Pediatric Oncology Group

Recruiting

Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma (GFARB12019)

Retinoblastoma

Burkina Faso, Congo, The Democratic Republic of the, Côte D'Ivoire, Madagascar, Mali, Senegal
French Africa Pediatric Oncology Group

Recruiting

Therapeutic Recommendations for Nephroblastoma (GFANEPHRO20)

Nephroblastoma

Burkina Faso, Congo, The Democratic Republic of the, Côte D'Ivoire, Mali, Senegal, Madagascar
AORTICA Group
Salamanca University Hospital; Instituto de Investigación Biomédica de Salamanca

Completed

Cardiac COVID-19 Health Care Workers (CCC)

COVID-19 | SARS-CoV 2 | Myocarditis | Coronavirus | Cardiac Magnetic Resonance | Cardiac Anomaly

Spain
Floreo, Inc.
Cortica

Completed

Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)

Autism Spectrum Disorder

United States
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma (GFAOPLH2019)

Staging | Therapeutic Recommendations

France
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP (LALGFA2019)

Childhood ALL

Côte D'Ivoire, Senegal, Guinea
French Africa Pediatric Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa (RFAOP)

Pediatric Cancer

Burkina Faso, Cameroon, Congo, The Democratic Republic of the, Côte D'Ivoire, France, Gabon, Madagascar, Mali, Mauritania, Niger, Senegal, Togo
Cortice Biosciences, Inc.

Suspended

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma

Glioblastoma Multiforme

United States
Assistance Publique - Hôpitaux de Paris
ARTIC group (oncologists and urologists association)

Unknown

A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel (RisingPSA)

Adenocarcinoma of the Prostate

France
Thubrikar Aortic Valve, Inc.
KCRI

Recruiting

Safety and Performance Study of the Optimum Transcatheter Aortic Valve

Severe Aortic Stenosis

Poland
Cortice Biosciences, Inc.

Terminated

A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer

Prostate Cancer

United States
Cortice Biosciences, Inc.

Completed

Study of TPI 287 in Patients With Advanced Malignancies

Neoplasms | Hodgkin Disease | Non-Hodgkin Lymphoma

United States
Cortice Biosciences, Inc.

Terminated

Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy

Glioblastoma Multiforme

United States
Cortice Biosciences, Inc.

Terminated

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

Pancreatic Cancer

United States, Spain
Cortice Biosciences, Inc.

Completed

Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies

Neoplasms | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Amref Health Africa

Recruiting

Impact of the Financial Inclusion Improves Sanitation and Health (FINISH)

Health Knowledge, Attitudes, Practice

Kenya
Artiva Biotherapeutics, Inc.

Recruiting

AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States
Pfizer
Analysis Group; IMDC group

Completed

Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments

Metastatic Renal Cell Carcinoma (mRCC)

Canada
Artiva Biotherapeutics, Inc.

Recruiting

AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis

Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class III

United States
Artiva Biotherapeutics, Inc.

Not yet recruiting

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Breast Cancer | Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, United States
AGO Study Group
European Network of Gynaecological Oncological Trial Groups (ENGOT)

Recruiting

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

Germany
German Breast Group
AGO Study Group

Completed

Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer (GeparQuinto)

Breast Cancer

Germany
Groupe Hospitalier Diaconesses Croix Saint-Simon
GERCOR - Multidisciplinary Oncology Cooperative Group

Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer (CHIMOVIP)

Ovarian Cancer, Epithelial

France
German Breast Group
AGO Study Group

Completed

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)

Breast Cancer

Germany
Italian Sarcoma Group
Scandinavian Sarcoma Group; Cooperative Osteosarcoma Study Group

Completed

European Study in Bone Sarcoma Patients Over 40 Years (EUROBOSS)

Osteosarcoma | Spindle Cell Sarcoma of Bone

Italy, Germany, Sweden
Tera Group

Recruiting

Validation of TERA Bio Station T101 of COVID-19 Tested Population.

COVID-19

Turkey
Polaris Group

Recruiting

ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme (GBM)

Taiwan
RECORDATI GROUP

Recruiting

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Disease

Cushing's Disease

Italy, Belgium, Bulgaria, Slovenia, United Kingdom
RECORDATI GROUP

Recruiting

Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease

Cushings Disease

United States, Canada, Colombia, France, Germany, Israel, Italy, Lebanon, Netherlands, Romania, Sweden, United Kingdom
Menarini Group

Active, not recruiting

MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) (C-PRECISE-01)

Metastatic Colorectal Cancer

Spain, Italy, Netherlands, Germany, United States, France, Poland
RECORDATI GROUP

Active, not recruiting

Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome (LINC7)

Cushing's Syndrome

France
Menarini Group

Completed

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

Colic

United States
SVR Group

Withdrawn

Evaluation of the Efficacy of Topialyse Baume barrière on Atopic Dermatis (TOPIA)

Atopic Dermatitis
Polaris Group

Terminated

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Advanced Gastrointestinal (GI) Malignancies

United States, Taiwan, Korea, Republic of, United Kingdom, China, Italy
Menarini Group

Terminated

Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections (DRESS)

Surgical Site Infection

Italy
Raisio Group

Active, not recruiting

Lipid Lowering Effect of Plant Stanol Ester in a Drinkable Non-dairy Product

Hypercholesterolemia

Finland
Menarini Group

Terminated

MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I Study (CD205SHUTTLE)

Metastatic Solid Tumors | Relapsed/Refractory Non-Hodgkin Lymphoma

Italy, Spain, Belgium, United Kingdom
Menarini Group

Terminated

Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia (ARMY)

Recurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse

France, Germany, Italy, Spain, Belgium
UnitedHealth Group

Completed

Community-based Program to Treat Childhood Obesity

Childhood Obesity

United States
Menarini Group

Terminated

Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults (FLORET)

Tumor Lysis Syndrome

Spain, Hungary, Italy, Bulgaria
Menarini Group

Completed

Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third Molar (DAVID)

Acute Pain

Italy, Hungary, Spain, Poland, United Kingdom
Ictal Group

Unknown

Acute Encephalopathy in Critically Ill Patients With COVID-19 (NeuroCOVID19)

COVID-19 | Critically Ill | Encephalopathy

Egypt, France, United States, Brazil, Colombia, Mexico, Spain
Raisio Group

Completed

Lipid-lowering Effect of Plant Stanol Drink

Hypercholesterolemia

Sweden
Tiva Group

Unknown

Use of the Nasal Cannula During COVID-19

COVID 19

Argentina
Polaris Group

Completed

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Advanced Pancreatic Cancer

United States

Clinical Trials Sponsored by AORTICA Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations